rs689

Variant summary

Our verdict is . The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000207.3(INS):​c.-17-6T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.71 in 1,609,954 control chromosomes in the GnomAD database, including 415,985 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 32035 hom., cov: 35)
Exomes 𝑓: 0.72 ( 383950 hom. )

Consequence

INS
NM_000207.3 splice_region, intron

Scores

3
Splicing: ADA: 0.1228
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0740

Publications

239 publications found
Variant links:
Genes affected
INS (HGNC:6081): (insulin) This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000207.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-2160994-A-T is Benign according to our data. Variant chr11-2160994-A-T is described in ClinVar as Benign. ClinVar VariationId is 304059.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.926 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000207.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INS
NM_000207.3
MANE Select
c.-17-6T>A
splice_region intron
N/ANP_000198.1P01308-1
INS
NM_001185098.2
c.-23T>A
5_prime_UTR
Exon 1 of 2NP_001172027.1P01308-1
INS-IGF2
NM_001042376.3
c.-17-6T>A
splice_region intron
N/ANP_001035835.1F8WCM5-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INS
ENST00000397262.5
TSL:1
c.-23T>A
5_prime_UTR
Exon 1 of 2ENSP00000380432.1P01308-1
INS
ENST00000381330.5
TSL:1 MANE Select
c.-17-6T>A
splice_region intron
N/AENSP00000370731.5P01308-1
INS-IGF2
ENST00000397270.1
TSL:1
c.-17-6T>A
splice_region intron
N/AENSP00000380440.1F8WCM5-1

Frequencies

GnomAD3 genomes
AF:
0.611
AC:
92830
AN:
152032
Hom.:
32028
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.263
Gnomad AMI
AF:
0.666
Gnomad AMR
AF:
0.725
Gnomad ASJ
AF:
0.709
Gnomad EAS
AF:
0.947
Gnomad SAS
AF:
0.831
Gnomad FIN
AF:
0.792
Gnomad MID
AF:
0.788
Gnomad NFE
AF:
0.719
Gnomad OTH
AF:
0.669
GnomAD2 exomes
AF:
0.734
AC:
178240
AN:
242726
AF XY:
0.745
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.769
Gnomad ASJ exome
AF:
0.703
Gnomad EAS exome
AF:
0.953
Gnomad FIN exome
AF:
0.797
Gnomad NFE exome
AF:
0.720
Gnomad OTH exome
AF:
0.737
GnomAD4 exome
AF:
0.720
AC:
1049977
AN:
1457804
Hom.:
383950
Cov.:
61
AF XY:
0.725
AC XY:
525501
AN XY:
725156
show subpopulations
African (AFR)
AF:
0.245
AC:
8177
AN:
33438
American (AMR)
AF:
0.762
AC:
33884
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
18395
AN:
26076
East Asian (EAS)
AF:
0.959
AC:
38023
AN:
39664
South Asian (SAS)
AF:
0.827
AC:
71293
AN:
86168
European-Finnish (FIN)
AF:
0.792
AC:
40663
AN:
51324
Middle Eastern (MID)
AF:
0.789
AC:
4293
AN:
5442
European-Non Finnish (NFE)
AF:
0.713
AC:
792116
AN:
1110992
Other (OTH)
AF:
0.716
AC:
43133
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
17870
35741
53611
71482
89352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19814
39628
59442
79256
99070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.610
AC:
92854
AN:
152150
Hom.:
32035
Cov.:
35
AF XY:
0.624
AC XY:
46388
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.263
AC:
10901
AN:
41518
American (AMR)
AF:
0.725
AC:
11094
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.709
AC:
2461
AN:
3470
East Asian (EAS)
AF:
0.948
AC:
4894
AN:
5164
South Asian (SAS)
AF:
0.831
AC:
4010
AN:
4824
European-Finnish (FIN)
AF:
0.792
AC:
8397
AN:
10602
Middle Eastern (MID)
AF:
0.793
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
0.719
AC:
48839
AN:
67968
Other (OTH)
AF:
0.673
AC:
1422
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1574
3149
4723
6298
7872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.676
Hom.:
6698
Bravo
AF:
0.588
Asia WGS
AF:
0.841
AC:
2925
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Maturity-onset diabetes of the young type 10 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.2
DANN
Benign
0.75
PhyloP100
-0.074
PromoterAI
0.018
Neutral
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.12
dbscSNV1_RF
Benign
0.39
SpliceAI score (max)
0.38
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.38
Position offset: -6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.